logo-loader
viewCellmid Limited

Cellmid managing director and CEO lifts holding in life sciences company with on-market purchase

The company told Proactive Investors in February that it remained on track for record revenues in financial year 2019, targeting profitability in financial year 2020.

1557126832_6250581623_e06dfe930c_o.jpg
The company sells clinically validated anti-ageing products for hair, skin and body

Cellmid Limited (ASX:CDY) director Maria Halasz has demonstrated her confidence in the company with the purchase of 39,000 indirect shares at 21 cents a share in on-market trades.

The managing director and chief executive officer increased her holding to 1,585,938 fully paid ordinary shares.

READ: Cellmid’s évolis Professional product range to be sold in Europe

Last month the company registered its évolis Professional anti-ageing hair care products for sale in the European Union and the UK.

This represented the final step in a comprehensive regulatory compliance assessment of the products before they could be freely sold in Europe.

Cellmid also established a partnership with one of the largest cosmetics retailers in Europe and expects e-commerce sales on the partner’s platform will begin in the first half of the 2020 financial year.

READ: Cellmid alopecia patent granted in Europe for évolis hair therapy

The évolis Professional product range of all 11 SKUS will be sold in EU member states by Cellmid’s cosmetic retail partner.

Consistent with the company’s strategic plan released to the market at the end of February, the EU product registration represents yet another important milestone in the company’s plans for the global expansion of the évolis brand.

Quick facts: Cellmid Limited

Price: 0.245 AUD

ASX:CDY
Market: ASX
Market Cap: $23.67 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Cellmid Limited named herein, including the promotion by the Company of Cellmid Limited in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Cellmid makes key retail collaborations and continues to kick strategic goals

Cellmid Limited (ASX:CDY) chief executive officer and managing director Maria Halasz updates Proactive on a number of recent key announcements, including a new collaboration with a major retail chain in Europe, a new agreement to sell Evolis in 400 Priceline pharmacies and signing up with the...

3 weeks, 3 days ago

2 min read